Company News

Lupin receives USFDA nod for Generic Topicort LP Emollient Cream

Views: 2.0K

Pharma Major Lupin Limited (Lupin) announced that it has received final approval for its Desoximetasone Cream USP, 0.05% and Desoximetasone Cream USP, 0.25% from the United States Food and Drug Administration (FDA) to market a generic equivalent of Taro Pharmaceuticals North America, Incs Topicort LP Emollient Cream, 0.05% and Taro Pharmaceuticals, Incs (collectively Taro) Topicort® Cream, 0.25%.

Both products are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Topicort® LP emollient Cream had US sales of USD 33 mn (IMS MAT September 2016) while Topicort Cream had US sales of USD 17 mn (IMS MAT September 2016).

Latest News

To Top